Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Quon

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Radiology|February 9, 2016
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringRyogo Minamimoto, Luis Fayad, Ranjana Advani, et al.
Clinical Lung Cancer|March 16, 2015
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic FactorsJeremy P Harris, Christine N Chang-Halpenny, Peter G Maxim, et al.
Blood|September 22, 2009
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 studySandra J Horning, Malik E Juweid, Heiko Schöder, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab eraSusan M Hiniker, Erqi L Pollom, Michael S Khodadoust, et al.
Radiology|June 23, 2012
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary resultsOlivier Gevaert, Jiajing Xu, Chuong D Hoang, et al.
Molecular Imaging and Biology|November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMartin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Clinical Nuclear Medicine|December 10, 2014
Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image qualityAndrei Iagaru, Erik Mittra, Ryogo Minamimoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter studyRyogo Minamimoto, Luis Fayad, Julie Vose, et al.
American Journal of Clinical Oncology|March 23, 2011
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancerSravana K Chennupati, Andrew Quon, Aya Kamaya, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2012
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancerPriya Jayachandran, Reetesh K Pai, Andrew Quon, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Radiology|February 9, 2016
Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringRyogo Minamimoto, Luis Fayad, Ranjana Advani, et al.
Clinical Lung Cancer|March 16, 2015
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic FactorsJeremy P Harris, Christine N Chang-Halpenny, Peter G Maxim, et al.
Blood|September 22, 2009
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 studySandra J Horning, Malik E Juweid, Heiko Schöder, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab eraSusan M Hiniker, Erqi L Pollom, Michael S Khodadoust, et al.
Radiology|June 23, 2012
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary resultsOlivier Gevaert, Jiajing Xu, Chuong D Hoang, et al.
Molecular Imaging and Biology|November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMartin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Clinical Nuclear Medicine|December 10, 2014
Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image qualityAndrei Iagaru, Erik Mittra, Ryogo Minamimoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter studyRyogo Minamimoto, Luis Fayad, Julie Vose, et al.
American Journal of Clinical Oncology|March 23, 2011
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancerSravana K Chennupati, Andrew Quon, Aya Kamaya, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2012
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancerPriya Jayachandran, Reetesh K Pai, Andrew Quon, et al.
Pageof 10